A Cloned Frog Vasoactive Intestinal Polypeptide/ Pituitary Adenylate Cyclase-Activating Polypeptide Receptor Exhibits Pharmacological and Tissue Distribution Characteristics of Both VPAC1 and VPAC2 Receptors in Mammals.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Endocrinology

• Publication date

  1999-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/endo.140.3.6576PMID 28204296
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.

  1998influential reference
• Site-directed mutagenesis of human vasoactive intestinal peptide receptor subtypes VIP1 and VIP2: evidence for difference in the structure-function relationship.

  1998cited by this paper
• Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production.

  1997cited by this paper
• Two protochordate genes encode pituitary adenylate cyclase-activating polypeptide and related family members.

  1997cited by this paper
• Expression and Alternative Processing of a Chicken Gene Encoding Both Growth Hormone-Releasing Hormone and Pituitary Adenylate Cyclase-Activating Polypeptide

  1997cited by this paper
• Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation.

  1997cited by this paper
• A disulfide bond between conserved cysteines in the extracellular loops of the human VIP receptor is required for binding and activation

  1997cited by this paper
• Molecular evolution of vertebrate VIP receptors and functional characterization of a VIP receptor from goldfish Carassius auratus.

  1997cited by this paper
• Exon Skipping in the Gene Encoding Pituitary Adenylate Cyclase-Activating Polypeptide in Salmon Alters the Expression of Two Hormones that Stimulate Growth Hormone Release1.

  1997cited by this paper
• Exon skipping in the gene encoding pituitary adenylate cyclase-activating polypeptide in salmon alters the expression of two hormones that stimulate growth hormone release.

  1997cited by this paper
• Molecular cloning of frog secretogranin II reveals the occurrence of several highly conserved potential regulatory peptides

  1996cited by this paper
• Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland.

  1996cited by this paper
• Vasoactive Intestinal Peptide (VIP)1 Receptor

  1996influential reference
• Comparative Vertebrate Neuroanatomy: Evolution and Adaptation

  1996cited by this paper
• Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane.

  1996cited by this paper
• Occurrence of two somatostatin variants in the frog brain: characterization of the cDNAs, distribution of the mRNAs, and receptor-binding affinities of the peptides.

  1996cited by this paper
• Tissue Specific Expression of Different Human ReceptorTypes for Pituitary Adenylate Cyclase Activating Polypeptideand Vasoactive Intestinal Polypeptide: Implications fortheir Role in Human Physiology

  1996cited by this paper
• Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP.

  1995cited by this paper
• The distribution of vasoactive intestinal peptide2 receptor messenger RNA in the rat brain and pituitary gland as assessed by in situ hybridization.

  1995cited by this paper
• Sequence and expression of cDNA for pituitary adenylate cyclase activating polypeptide (PACAP) and growth hormone-releasing hormone (GHRH)-like peptide in catfish.

  1995cited by this paper
• Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.

  1995cited by this paper
• Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination.

  1995cited by this paper
• Frog vasoactive intestinal polypeptide and galanin: primary structures and effects on pituitary adenylate cyclase.

  1995cited by this paper
• Mutational analysis of cysteine residues within the extracellular domains of the human vasoactive intestinal peptide (VIP) 1 receptor identifies seven mutants that are defective in VIP binding.

  1995cited by this paper
• Molecular cloning and functional characterization of a human secretin receptor.

  1995cited by this paper
• Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Its Receptors: Neuroendocrine and Endocrine Interaction

  1995cited by this paper
• Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells.

  1994cited by this paper
• The human glucagon receptor encoding gene: structure, cDNA sequence and chromosomal localization.

  1994cited by this paper
• Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions.

  1994influential reference
• Pituitary adenylate cyclase-activating polypeptide stimulates both adrenocortical cells and chromaffin cells in the frog adrenal gland.

  1994cited by this paper
• Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor.

  1993influential reference
• Differential signal transduction by five splice variants of the PACAP receptor

  1993cited by this paper
• Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor.

  1993cited by this paper
• The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide

  1993cited by this paper
• Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research

  1992cited by this paper
• Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide.

  1992influential reference
• Primary structure of frog pituitary adenylate cyclase-activating polypeptide (PACAP) and effects of ovine PACAP on frog pituitary.

  1991cited by this paper
• Molecular cloning and characterization of cDNA for the precursor of rat pituitary adenylate cyclase activating polypeptide (PACAP).

  1990cited by this paper
• Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38).

  1990cited by this paper
• Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells.

  1989cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• A new method for predicting signal sequence cleavage sites.

  1986cited by this paper
• Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27

  1983cited by this paper

• PACAP and its role in primary headaches

  2018cites this paper
• Expression Analysis of PAC1-R and PACAP Genes in Zebrafish Embryos

  2010cites this paper
• Neuroendocrine Regulation of Thyroid‐stimulating Hormone Secretion in Amphibians

  2009cites this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery

  2009cites this paper
• VIP and PACAP stimulate TSH release from the bullfrog pituitary.

  2007cites this paper
• Motricite vésiculaire et oddienne : physiologie et physiopathologie

  2007cites this paper
• Molecular evolution of neuropeptide receptors with regard to maintaining high affinity to their authentic ligands.

  2007cites this paper
• Ontogeny of PAC1-R and VPAC1-R in the frog, Rana esculenta.

  2007cites this paper
• PACAP, VIP and their receptors in the metazoa: insights about the origin and evolution of the ligand-receptor pair.

  2007cites this paper
• Cloning and characterization of a PAC1 receptor hop-1 splice variant in goldfish (Carassius auratus).

  2006cites this paper
• Expression of PACAP Receptors in the Frog Brain during Development

  2006cites this paper
• Effects of Pituitary Adenylate Cyclase‐Activating Polypeptide, Vasoactive Intestinal Polypeptide, and Somatostatin on the Release of Thyrotropin from the Bullfrog Pituitary

  2006cites this paper
• Molecular cloning, pharmacological characterization, and histochemical distribution of frog vasotocin and mesotocin receptors.

  2004cites this paper
• Duplicated receptors for VIP and PACAP (VPAC1R and PAC1R) in a teleost fish, Fugu rubripes.

  2004cites this paper
• Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.

  2004cites this paper
• Regional Concentration and Chromatographic Characterization of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in the Brain of the Bullfrog, Rana catesbeiana

  2003cites this paper
• Localisation of VIP-binding sites exhibiting properties of VPAC receptors in chromaffin cells of rainbow trout (Oncorhynchus mykiss)

  2003cites this paper
• Molecular characterization of the cDNA and localization of the mRNA encoding the prohormone convertase PC5‐A in the European green frog

  2003cites this paper
• The Biological Significance of PACAP and PACAP Receptors in Human Tumors: From Cell Lines to Cancers

  2003cites this paper
• Molecular evolution of PACAP precursor and PACAP receptors

  2003cites this paper
• Novel Splice Variants of Type I Pituitary Adenylate Cyclase-Activating Polypeptide Receptor in Frog Exhibit Altered Adenylate Cyclase Stimulation and Differential Relative Abundance.

  2002influential citation
• Comparative distributions of pituitary adenylyl cyclase-activating polypeptide and its selective type I receptor mRNA in the frog (Xenopus laevis) brain.

  2002cites this paper
• Neuropeptide Y Inhibits Spontaneous α-Melanocyte-Stimulating Hormone (α-MSH) Release via a Y5 Receptor and Suppresses Thyrotropin-Releasing Hormone-Induced α-MSH Secretion via a Y1 Receptor in Frog Melanotrope Cells.

  2002cites this paper
• Comparative distribution of VIP in the central nervous system of various species measured by a new radioimmunoassay.

  2002cites this paper
• The control of gut motility.

  2001cites this paper
• Pituitary adenylate cyclase‐activating polypeptide and its receptors in amphibians

  2001influential citation
• Ontogeny of pituitary adenylate cyclase‐activating polypeptide (PACAP) in the frog (Rana ridibunda) tadpole brain: Immunohistochemical localization and biochemical characterization

  2001cites this paper
• Evolution of receptors for proglucagon-derived peptides: isolation of frog glucagon receptors.

  2001cites this paper
• Molecular Cloning of Chicken Vasoactive Intestinal Polypeptide Receptor Complementary DNA, Tissue Distribution and Chromosomal Localization1

  2001cites this paper
• Structural and functional identification of the pituitary adenylate cyclase-activating polypeptide receptor VPAC2 from the frog Rana tigrina rugulosa.

  2001cites this paper
• Molecular Cloning, mRNA Distribution and Pharmacological Characterization of a VIP/PACAP Receptor in the Frog Rana ridibunda

  2000cites this paper
• Molecular Cloning of Growth Hormone-Releasing Hormone/Pituitary Adenylyl Cyclase-Activating Polypeptide in the Frog Xenopus laevis: Brain Distribution and Regulation after Castration1†.

  2000cites this paper
• Characterization and Messenger Ribonucleic Acid Distribution of a Cloned Pituitary Adenylate Cyclase-Activating Polypeptide Type I Receptor in the Frog Xenopus laevis Brain1.

  2000cites this paper
• Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.

  2000cites this paper
• Structure and distribution of the mRNAs encoding pituitary adenylate cyclase‐activating polypeptide and growth hormone‐releasing hormone‐like peptide in the frog, Rana ridibunda

  2000cites this paper
• THE ORIGIN AND FUNCTION OF THE PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP)/GLUCAGON SUPERFAMILY

  2000cites this paper
• Molecular evolution of the growth hormone-releasing hormone/pituitary adenylate cyclase-activating polypeptide gene family. Functional implication in the regulation of growth hormone secretion.

  2000cites this paper
• The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily.

  2000cites this paper
• PACAP and nitric oxide inhibit contractions in the proximal intestine of the atlantic cod, Gadus morhua.

  2000influential citation
• Characterization and messenger ribonucleic acid distribution of a cloned pituitary adenylate cyclase-activating polypeptide type I receptor in the frog Xenopus laevis brain.

  2000influential citation
• Molecular Cloning of Growth Hormone-releasing Hormone/pituitary Adenylyl Cyclase-activating Polypeptide in the Frog Xenopus Laevis: Brain Distribution and Regulation after Castration* †

  1999cites this paper